ANVISA authorized regulations that are new the roll-out of medicinal items produced by cannabis
The Brazilian Health Regulatory Agency (ANVISA) authorized, at the start of December 2019, laws that enable the purchase in pharmacies of cannabis-based services and products for medical purposes. The procedures for manufacturing and importing such products and the requirements for prescription, sale, and supervision are approved in these new proposals. Authorization will not consist of substance managing in pharmacies and it is just permitted to offer – by prescription – items currently developed straight through the maker. The authorized guidelines will continue to be in force for 36 months, and after that a brand new standard would be given, thinking about the outcomes acquired in this initial duration.